naphazoline and olopatadine hydrochloride

naphazoline has been researched along with olopatadine hydrochloride in 3 studies

Research

Studies (3)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (33.33)	29.6817
2010's	1 (33.33)	24.3611
2020's	1 (33.33)	2.80

Authors

Authors	Studies
Greiner, JV; Udell, IJ	1
He, H; Quan, L	1
Brafford, R; Christensen, M; Franklin, Q; Hogan, C; Kelley, LR; Lievens, C; Logan, A; McGwin, G; Pucker, AD	1

Trials

1 trial(s) available for naphazoline and olopatadine hydrochloride

Article	Year
A comparison of the clinical efficacy of pheniramine maleate/naphazoline hydrochloride ophthalmic solution and olopatadine hydrochloride ophthalmic solution in the conjunctival allergen challenge model. Clinical therapeutics, 2005, Volume: 27, Issue:5 Topics: Administration, Topical; Adult; Aged; Allergens; Anti-Allergic Agents; Conjunctivitis, Allergic; Dibenzoxepins; Double-Blind Method; Drug Combinations; Female; Humans; Male; Middle Aged; Naphazoline; Olopatadine Hydrochloride; Ophthalmic Solutions; Pheniramine	2005

Article

Year

A comparison of the clinical efficacy of pheniramine maleate/naphazoline hydrochloride ophthalmic solution and olopatadine hydrochloride ophthalmic solution in the conjunctival allergen challenge model.

Clinical therapeutics, 2005, Volume: 27, Issue:5

Topics: Administration, Topical; Adult; Aged; Allergens; Anti-Allergic Agents; Conjunctivitis, Allergic; Dibenzoxepins; Double-Blind Method; Drug Combinations; Female; Humans; Male; Middle Aged; Naphazoline; Olopatadine Hydrochloride; Ophthalmic Solutions; Pheniramine

2005

Other Studies

2 other study(ies) available for naphazoline and olopatadine hydrochloride

Article	Year
Treatment with olopatadine and naphazoline hydrochloride reduces allergic conjunctivitis in mice through alterations in inflammation, NGF and VEGF. Molecular medicine reports, 2016, Volume: 13, Issue:4 Topics: Animals; Blotting, Western; Conjunctivitis, Allergic; Cytokines; Disease Models, Animal; Drug Therapy, Combination; Enzyme-Linked Immunosorbent Assay; Female; Granulocyte-Macrophage Colony-Stimulating Factor; Histamine; Immunoglobulin E; Mice; Mice, Inbred BALB C; Naphazoline; Nerve Growth Factor; Olopatadine Hydrochloride; Ovalbumin; Vascular Endothelial Growth Factor A	2016
Understanding ocular comfort differences between 0.7% olopatadine and 0.3% pheniramine maleate/0.025% naphazoline hydrochloride eye drops. Clinical & experimental optometry, 2023, Volume: 106, Issue:5 Topics: Adolescent; Adult; Conjunctivitis, Allergic; Dibenzoxepins; Double-Blind Method; Humans; Naphazoline; Olopatadine Hydrochloride; Ophthalmic Solutions; Pheniramine; Young Adult	2023

Article

Year

Treatment with olopatadine and naphazoline hydrochloride reduces allergic conjunctivitis in mice through alterations in inflammation, NGF and VEGF.

Molecular medicine reports, 2016, Volume: 13, Issue:4

Topics: Animals; Blotting, Western; Conjunctivitis, Allergic; Cytokines; Disease Models, Animal; Drug Therapy, Combination; Enzyme-Linked Immunosorbent Assay; Female; Granulocyte-Macrophage Colony-Stimulating Factor; Histamine; Immunoglobulin E; Mice; Mice, Inbred BALB C; Naphazoline; Nerve Growth Factor; Olopatadine Hydrochloride; Ovalbumin; Vascular Endothelial Growth Factor A

2016

Understanding ocular comfort differences between 0.7% olopatadine and 0.3% pheniramine maleate/0.025% naphazoline hydrochloride eye drops.

Clinical & experimental optometry, 2023, Volume: 106, Issue:5

Topics: Adolescent; Adult; Conjunctivitis, Allergic; Dibenzoxepins; Double-Blind Method; Humans; Naphazoline; Olopatadine Hydrochloride; Ophthalmic Solutions; Pheniramine; Young Adult

2023